Sustained Exogenous Expression of Therapeutic Levels of IFN-γ Ameliorates Atopic Dermatitis in NC/Nga Mice via Th1 Polarization

No abstract is available for this paper.

• Publication year

  2010

• Venue

  Journal of Immunology

• Publication date

  2010-03-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.4049/jimmunol.0900215PMID 20107184
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Cutaneous hypersensitivities to hapten are controlled by IFN-γ-upregulated keratinocyte Th1 chemokines and IFN-γ-downregulated Langerhans cell Th2 chemokines

  2009cited by this paper
• Effect of the content of unmethylated CpG dinucleotides in plasmid DNA on the sustainability of transgene expression

  2009cited by this paper
• Cutaneous hypersensitivities to hapten are controlled by IFN-gamma-upregulated keratinocyte Th1 chemokines and IFN-gamma-downregulated langerhans cell Th2 chemokines.

  2008cited by this paper
• Computer-assisted hydrodynamic gene delivery.

  2008cited by this paper
• Direct comparison of hepatocyte-specific expression cassettes following adenoviral and nonviral hydrodynamic gene transfer

  2008cited by this paper
• Reactivation of Silenced Transgene Expression in Mouse Liver by Rapid, Large-Volume Injection of Isotonic Solution

  2008cited by this paper
• Minimally invasive and selective hydrodynamic gene therapy of liver segments in the pig and human

  2008cited by this paper
• Improved anti‐cancer effect of interferon gene transfer by sustained expression using CpG‐reduced plasmid DNA

  2007cited by this paper
• Cytokines in atopic diseases: revisiting the Th2 dogma.

  2006cited by this paper
• PEGylated catalase prevents metastatic tumor growth aggravated by tumor removal.

  2006cited by this paper
• Enhancement of periodontal tissue regeneration by locally controlled delivery of insulin-like growth factor-I from dextran-co-gelatin microspheres.

  2006cited by this paper
• Multivesicular liposome formulations for the sustained delivery of interferon α-2b

  2005cited by this paper
• The hydrodynamics-based procedure for controlling the pharmacokinetics of gene medicines at whole body, organ and cellular levels.

  2005cited by this paper
• Interferon-γ Inhibits in vitro Mobilization of Eosinophils by Interleukin-5

  2005cited by this paper
• Inhibition of metastatic tumor growth by targeted delivery of antioxidant enzymes.

  2005cited by this paper
• Sustained interferon-γ delivery from a photocrosslinked biodegradable elastomer

  2005cited by this paper
• The increased prevalence of allergy and the hygiene hypothesis: missing immune deviation, reduced immune suppression, or both?

  2004cited by this paper
• Hydrodynamics‐based procedure involves transient hyperpermeability in the hepatic cellular membrane: implication of a nonspecific process in efficient intracellular gene delivery

  2004cited by this paper
• Significance of the cytokine interferon gamma in clinical dermatology

  2004cited by this paper
• Thymus and activation-regulated chemokine (TARC/CCL17) produced by mouse epidermal Langerhans cells is upregulated by TNF-alpha and IL-4 and downregulated by IFN-gamma.

  2003cited by this paper
• Therapeutic effect of intravenous interferon gene delivery with naked plasmid DNA in murine metastasis models.

  2002cited by this paper
• CpG-depleted plasmid DNA vectors with enhanced safety and long-term gene expression in vivo.

  2002cited by this paper
• Interferon‐γ therapy: Evaluation of routes of administration and delivery systems

  2002cited by this paper
• Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam technology.

  2001cited by this paper
• Clinical applications of a novel sustained-release injectable drug delivery system: DepoFoam technology.

  2001cited by this paper
• Improved pharmacokinetic properties of a polyethylene glycol-modified form of interferon-beta-1a with preserved in vitro bioactivity.

  2001cited by this paper
• Pegylation: a novel process for modifying pharmacokinetics.

  2001cited by this paper
• Clinical improvement and immunohistochemical findings in severe atopic dermatitis treated with interferon gamma.

  2000cited by this paper
• Overproduction of Th2-specific chemokines in NC/Nga mice exhibiting atopic dermatitis-like lesions.

  1999cited by this paper
• Gene expression and antitumor effects following direct interferon (IFN)-γ gene transfer with naked plasmid DNA and DC-chol liposome complexes in mice

  1999cited by this paper
• Interferon-gamma therapy reduces blood leukocyte levels in patients with atopic dermatitis: correlation with clinical improvement.

  1999cited by this paper
• Chemokines: signal lamps for trafficking of T and B cells for development and effector function

  1999cited by this paper
• Roles of TH1 and TH2 cytokines in a murine model of allergic dermatitis.

  1999cited by this paper
• Hydrodynamics-based transfection in animals by systemic administration of plasmid DNA

  1999cited by this paper
• Blood eosinophils and serum IgE as predictors for prognosis of interferongamma therapy in atopic dermatitis

  1998cited by this paper
• Chemokines--chemotactic cytokines that mediate inflammation.

  1998cited by this paper
• Long-term effectiveness and safety of recombinant human interferon gamma therapy for atopic dermatitis despite unchanged serum IgE levels.

  1998cited by this paper
• The millennium criteria for the diagnosis of atopic dermatitis

  1998cited by this paper
• A role for Th1 and Th2 cells in the immunopathogenesis of atopic dermatitis.

  1998cited by this paper
• The relative contribution of IL-4 and IL-13 to human IgE synthesis induced by activated CD4+ or CD8+ T cells.

  1997cited by this paper
• Scratching behavior induced by pruritogenic but not algesiogenic agents in mice.

  1995cited by this paper
• Atopic dermatitis--immunological abnormality and its background.

  1994cited by this paper
• Interferon gamma inhibits interleukin 10 production by monocytes

  1993cited by this paper
• Interferon gamma regulates antigen-induced eosinophil recruitment into the mouse airways by inhibiting the infiltration of CD4+ T cells

  1993cited by this paper
• Human Th1 and Th2 lymphocytes: their role in the pathophysiology of atopy.

  1992cited by this paper
• Development of Atopic Dermatitis-like Skin Lesion with Ige Hyperproduction in Nc/nga Mice

  year unknowncited by this paper

• Deep Sea Minerals Ameliorate Dermatophagoides Farinae- or 2,4-Dinitrochlorobenzene-Induced Atopic Dermatitis-like Skin Lesions in NC/Nga Mice

  2025cites this paper
• Novel insights: crosstalk with non-puerperal mastitis and immunity

  2024cites this paper
• The Influence of Skin Microbial Ecology on γδ T Cell Immune Pathways in Allergic Dermatitis Models in Mice.

  2024cites this paper
• A pilot study to evaluate the potential therapeutic effect of hydrogen-water bathing on atopic dermatitis in humans

  2023cites this paper
• Antiallergic Effects of Callerya atropurpurea Extract In Vitro and in an In Vivo Atopic Dermatitis Model

  2023cites this paper
• Exercise-induced modulation of Interferon-signature: a therapeutic route toward management of Systemic Lupus Erythematosus.

  2023cites this paper
• Inhibitory Effects of Grewia tomentosa Juss. on IgE-Mediated Allergic Reaction and DNCB-Induced Atopic Dermatitis

  2022cites this paper
• Modeling of indirect cell-cell interaction networks mediated by IFNγ/IL-4 cytokine involved in atopic dermatitis.

  2022cites this paper
• IFN-γ, should not be ignored in SLE

  2022cites this paper
• Expression of LINC00847 in Peripheral Blood Mononuclear Cells of Children with Asthma and Its Prediction between Asthma Exacerbation and Remission

  2022cites this paper
• MC5R Contributes to Sensitivity to UVB Waves and Barrier Function in Mouse Epidermis

  2021cites this paper
• Repeated α-GalCer Administration Induces a Type 2 Cytokine-Biased iNKT Cell Response and Exacerbates Atopic Skin Inflammation in Vα14Tg NC/Nga Mice

  2021cites this paper
• ArticleRepeated α-GalCer Administration Induces a Type

  2021cites this paper
• Effect of combined propofol-sevoflurane anesthesia on immune function in pediatric patients with acute lymphoblastic leukemia

  2019cites this paper
• I. inflexus (Thunb.) Kudo extract improves atopic dermatitis and depressive-like behavior in DfE-induced atopic dermatitis-like disease.

  2019cites this paper
• Regulation of Allergic Immune Responses by Microbial Metabolites

  2018cites this paper
• A novel mouse model of atopic dermatitis that is T helper 2 (Th2)-polarized by an epicutaneous allergen.

  2018cites this paper
• Therapeutic Effects of Bifidobacterium Longum Kacc 91563 on Dncb-Induced Atopic Dermatitis-Like Skin Lesions in Nc / Nga Mice

  2018cites this paper
• Targeted Delivery of Interferon Gamma Using a Recombinant Fusion Protein of a Fibrin Clot-Binding Peptide With Interferon Gamma for Cancer Gene Therapy.

  2017cites this paper
• The etiopathogenesis of atopic dermatitis: barrier disruption, immunological derangement, and pruritus

  2017cites this paper
• Oxymatrine Sensitizes the HaCaT Cells to the IFN-γ Pathway and Downregulates MDC, ICAM-1, and SOCS1 by Activating p38, JNK, and Akt

  2017cites this paper
• [Optimization of emollient formulation for treating atopic dermatitis by skin physiological index testing].

  2017cites this paper
• Depressive symptoms as a side effect of Interferon-α therapy induced by induction of indoleamine 2,3-dioxygenase 1

  2016cites this paper
• Identification of Th1/Th2 regulatory switch to promote healing response during leishmaniasis: a computational approach

  2015cites this paper
• Protective effect of diet supplemented with rice prolamin extract against DNCB-induced atopic dermatitis in BALB/c mice

  2015cites this paper
• Contribution of Epigenetic Modifications to the Decline in Transgene Expression from Plasmid DNA in Mouse Liver

  2015cites this paper
• Inhibitory/suppressive oligodeoxynucleotide nanocapsules as simple oral delivery devices for preventing atopic dermatitis in mice.

  2015cites this paper
• In vivo assessment of the effect of taxifolin glycoside on atopic dermatitis‐like skin lesions using biomedical tools in NC/Nga mice

  2015cites this paper
• Probiotic fermented milk consumption modulates the allergic process induced by ovoalbumin in mice

  2015cites this paper
• Prevention of adverse events of interferon γ gene therapy by gene delivery of interferon γ-heparin-binding domain fusion protein in mice

  2014cites this paper
• Positive Effects of hydrogen water on 2,4-dinitrochlorobenzene-induced atopic dermatitis in NC/Nga mice.

  2014cites this paper
• 7,8,4′-Trihydroxyisoflavone Attenuates DNCB-Induced Atopic Dermatitis-Like Symptoms in NC/Nga Mice

  2014cites this paper
• Multifunctional enveloped nanodevices (MENDs).

  2014cites this paper
• Effects of upregulated indoleamine 2, 3-dioxygenase 1 by interferon γ gene transfer on interferon γ-mediated antitumor activity

  2014cites this paper
• Reovirus type-2–triggered autoimmune cholangitis in extrahepatic bile ducts of weanling DBA/1J mice

  2014cites this paper
• Oral administration of poly-γ-glutamate ameliorates atopic dermatitis in Nc/Nga mice by suppressing Th2-biased immune response and production of IL-17A.

  2014cites this paper
• Generation of a chimeric dust mite hypoallergen using DNA shuffling for application in allergen-specific immunotherapy.

  2014cites this paper
• Neutralized Nanoparticle Composed of SS‐Cleavable and pH‐Activated Lipid‐Like Material as a Long‐Lasting and Liver‐Specific Gene Delivery System

  2014cites this paper
• Original Article Generation of a chimeric dust mite hypoallergen using DNA shuffling for application in allergen-specific immunotherapy

  2014cites this paper
• Neonatal Vaccination with Plasmid DNA Encoding Cyn d 1 Effectively Prevents Allergic Responses in Mice

  2014cites this paper
• Expression profile-dependent improvement of insulin sensitivity by gene delivery of interleukin-6 in a mouse model of type II diabetes.

  2013cites this paper
• New concept of the pathogenesis of atopic dermatitis: interplay among the barrier, allergy, and pruritus as a trinity.

  2013cites this paper
• Effects of Oral Administration of Probiotics from Mongolian Dairy Products on the Th1 Immune Response in Mice

  2013cites this paper
• Long-Term Elimination of Hepatitis C Virus from Human Hepatocyte Chimeric Mice After Interferon-γ Gene Transfer

  2013cites this paper
• Gene therapy of atopic dermatitis and cancer by sustained expression of interferon-γ in mice

  2013cites this paper
• Extended Duration of Transgene Expression from Pegylated POD Nanoparticles Enables Attenuation of Photoreceptor Degeneration

  2013cites this paper
• Gene delivery of albumin binding peptide-interferon-gamma fusion protein with improved pharmacokinetic properties and sustained biological activity.

  2013cites this paper
• Cytokines as biomarkers of nanoparticle immunotoxicity.

  2013cites this paper
• Regulation of immunological balance by sustained interferon-γ gene transfer for acute phase of atopic dermatitis in mice

  2012cites this paper
• Administration of poly(I:C) improved dermatophagoides farinae-induced atopic dermatitis-like skin lesions in NC/Nga mice by the regulation of Th1/Th2 balance.

  2012cites this paper
• Flaky Tail Mouse as a Novel Animal Model of Atopic Dermatitis: Possible Roles of Filaggrin in the Development of Atopic Dermatitis

  2012cites this paper
• [Control of spatiotemporal distribution of interferon γ by genetically fusing functional peptides].

  2012cites this paper
• Topical Application of Chrysanthemum indicum L. Attenuates the Development of Atopic Dermatitis-Like Skin Lesions by Suppressing Serum IgE Levels, IFN-γ, and IL-4 in Nc/Nga Mice

  2012cites this paper
• [Development of target-specific gene therapy system by controlling distribution of interferon].

  2012cites this paper
• Pathomechanism of atopic dermatitis in the perspective of T cell subsets and skin barrier functions – “Which comes first, the chicken or the egg?”

  2012cites this paper
• Low susceptibility of NC/Nga mice to the lipopolysaccharide-mediated lethality with d-galactosamine sensitization and the involvement of fewer natural killer T cells

  2012cites this paper
• Constant and steady transgene expression of interferon‐γ by optimization of plasmid construct for safe and effective interferon‐γ gene therapy

  2012cites this paper
• Development of safe and effective nonviral gene therapy by eliminating CpG motifs from plasmid DNA vector.

  2012cites this paper
• Inhibitory effects of Schizandra chinensis extract on atopic dermatitis in NC/Nga mice

  2012cites this paper
• CpG-free plasmid expression cassettes for cystic fibrosis gene therapy.

  2012influential citation
• Mixture of Polyphenols and Anthocyanins from Vaccinium uliginosum L. Alleviates DNCB-Induced Atopic Dermatitis in NC/Nga Mice

  2012cites this paper
• Induction of Specific Th1 Responses and Suppression of IgE Antibody Formation by Vaccination with Plasmid DNA Encoding Cyn d 1

  2012cites this paper
• Recent findings in mouse models for human atopic dermatitis.

  2012cites this paper
• Recombinant human interferon gamma (Gamma Immunex) in treatment of atopic dermatitis

  2012cites this paper
• Controlling the kinetics of interferon transgene expression for improved gene therapy

  2012cites this paper
• Prolonged circulation half-life of interferon γ activity by gene delivery of interferon γ-serum albumin fusion protein in mice.

  2011cites this paper
• Prevention of peritoneal adhesions: a promising role for gene therapy.

  2011cites this paper
• Inhibition of nuclear delivery of plasmid DNA and transcription by interferon γ: hurdles to be overcome for sustained gene therapy

  2011cites this paper
• B cell ADAM10 Activity is Increased by Kainate Receptor Activation: Potential Role of this Pathway in Th2 Immunity and Cancer

  2010cites this paper
• [Optimization of gene therapy effect by spaciotemporal control of expressed proteins].

  2010cites this paper
• Quoi de neuf en recherche dermatologique

  2010cites this paper
• [What's new in dermatological research?].

  2010cites this paper
• A Thesis for the Degree of Master of Science 7,8,4’-Trihydroxyisoflavone, a metabolite of soybean isoflavone, attenuates the DNCB-induced atopic dermatitis-like symptoms in NC/Nga mice

  2008cites this paper